SUN PHARMA (SUNPHARMA) - Live BSE, NSE Stock Quotes - SUN PHARMA Analysis Update - Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA   (SUNP)

REFRESH
Live BSE Quotes Aug 31, 2016 (Close)
Price (Rs)774.85 Open (Rs) 778.95 High (Rs) 781.95 Low (Rs) 772.50
% Change0.04 Volume 193,202 Value (Rs) 150,330,822 52-Week H/L 933.70 / 706.40
Live NSE Quotes Aug 31, 2016 (Close)
Price (Rs)775.65 Open (Rs) 778.00 High (Rs) 782.00 Low (Rs) 771.30
% Change0.10 Volume 3,405,144 Value (Rs) 2,647,707,786 52-Week H/L 933.95 / 704.00
Valuation
EPS (Rs)* 30.28 P/E Ratio (x) 25.59 Market Cap (Rs m) 1,604,838.33 P/BV (x) 6.26
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
SUN PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new

Related Views On News

Sun Pharma: Acquisition synergies start contributing (Quarterly Results Update - Detailed)

Apr 1, 2016

Sun Pharma has announced its 3QFY16 results. Net sales have grown by 2.3% YoY, while net profits surged by 258% YoY. Here is our analysis of the results.

Sun Pharma: Regulatory issues get more serious (Quarterly Results Update - Detailed)

Nov 17, 2015

Sun Pharma has announced its 2QFY16 results. The company has reported a 14.7% YoY decline in the topline, while net profits plummeted by 46% YoY. Here is our analysis of the results.

Glenmark: Margins under Pressure (Quarterly Results Update - Detailed)

Jun 22, 2016

Glenmark has announced its 4QFY16 results. The company has reported 30.5% YoY growth in sales and 1255.8% YoY increase in net profits. Here is our analysis of the results.

Lupin: Niche products boost business growth (Quarterly Results Update - Detailed)

Jun 15, 2016

Lupin has announced its 4QFY16 results. Net sales have grown by 38.6% YoY, while net profits declined by 54.8% YoY. Here is our analysis of the results.

Cipla: Impacted by one offs (Quarterly Results Update - Detailed)

Jun 2, 2016

Cipla has announced its 4QFY16 results. The company has reported 7.6% YoY growth in sales and a decline of 68.9% YoY in net profits. Here is our analysis of the results.

More Views on News

Most Popular

Cut Interest Rates by 2 per cent: The New Economics of Nirmala Sitharaman(Vivek Kaul's Diary)

Aug 25, 2016

The commerce and industry minister wants the RBI to cut the repo rate by 200 basis points, without realising the negative implications of it.

The Rise and Fall of a Ten-Bagger: Welspun India(The 5 Minute Wrapup)

Aug 26, 2016

Why Equitymaster stopped recommending Welspun India since 2007...

Arbitrage Funds vs. Liquid Funds vs. Savings Bank A/C: How to Park Your Short-Term Funds(Outside View)

Aug 23, 2016

PersonalFN elucidates how to manage liquidity needs and deploy investible surplus productively.

Unicorns and Smallcap Dwarfs(Chart Of The Day)

Aug 20, 2016

The timeframe for tech startups becoming unicorns is shrinking.

GST and the Consumer(Outside View)

Aug 18, 2016

How will the consumer benefit in the long-run from GST?

More

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 5-YR ANALYSIS

Detailed Financial Information With Charts

COMPARE SUN PHARMA WITH

MARKET STATS